Pharmacological treatment of actinic keratosis
Actinic keratosis (AK) is a disease characterized by hyperkeratotic lesions on skin damaged by ultraviolet. radiation. These lesions may progress to squamous cell or basal cell carcinoma. Currently pharmacotherapy and different surgical procedures are used in AK therapy. The most common treatment options are 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and first and third generation retinoids (retinol, adapalene, tazarotene). Furthermore, research is being carried out in order to test new medications including nicotinamide, resiquimod, piroxicam, potassium dobesilate and oleogel based on a triterpene extract (betulin, betulinic acid). Recently, the preventive effect of acetylsalicylic acid and celecoxib has also been investigated..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:103 |
|---|---|
| Enthalten in: |
Przegląd Dermatologiczny - 103(2016), 4, Seite 330-336 |
| Sprache: |
Englisch ; Polnisch |
|---|
| Beteiligte Personen: |
Ewa Zwierzyńska [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Actinic keratosis |
|---|
| doi: |
10.5114/dr.2016.61784 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ039175286 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ039175286 | ||
| 003 | DE-627 | ||
| 005 | 20230308025858.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5114/dr.2016.61784 |2 doi | |
| 035 | |a (DE-627)DOAJ039175286 | ||
| 035 | |a (DE-599)DOAJa146cc97b02c41d7a805dca8277a1636 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a pol | ||
| 050 | 0 | |a RL1-803 | |
| 100 | 0 | |a Ewa Zwierzyńska |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacological treatment of actinic keratosis |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Actinic keratosis (AK) is a disease characterized by hyperkeratotic lesions on skin damaged by ultraviolet. radiation. These lesions may progress to squamous cell or basal cell carcinoma. Currently pharmacotherapy and different surgical procedures are used in AK therapy. The most common treatment options are 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and first and third generation retinoids (retinol, adapalene, tazarotene). Furthermore, research is being carried out in order to test new medications including nicotinamide, resiquimod, piroxicam, potassium dobesilate and oleogel based on a triterpene extract (betulin, betulinic acid). Recently, the preventive effect of acetylsalicylic acid and celecoxib has also been investigated. | ||
| 650 | 4 | |a actinic keratosis | |
| 650 | 4 | |a pharmacotherapy | |
| 650 | 4 | |a clinical studies | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Dermatology | |
| 700 | 0 | |a Anna Zawistowska |e verfasserin |4 aut | |
| 700 | 0 | |a Bogusława Pietrzak |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Przegląd Dermatologiczny |d Termedia Publishing House, 2017 |g 103(2016), 4, Seite 330-336 |w (DE-627)DOAJ000066761 |x 20849893 |7 nnns |
| 773 | 1 | 8 | |g volume:103 |g year:2016 |g number:4 |g pages:330-336 |
| 856 | 4 | 0 | |u https://doi.org/10.5114/dr.2016.61784 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/a146cc97b02c41d7a805dca8277a1636 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.termedia.pl/Pharmacological-treatment-of-actinic-keratosis,56,28158,1,1.html |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0033-2526 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2084-9893 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 103 |j 2016 |e 4 |h 330-336 | ||